In this issue of Immunology & Allergy Clinics, guest editor Dr. Cem Akin brings his considerable expertise to the topic of Mast Cell Disorders. Top experts in the field provide readers with information on the identification, management, and treatment of mast cell disorders and mastocytosis.
Contains 9 relevant, practice-oriented topics including drug and venom allergy in mastocytosis; quality of life in mastocytosis; effect of gender and special considerations for women in mastocytosis and anaphylaxis; management of mediator symptoms, allergy, and anaphylaxis in mastocytosis; and more.
Provides in-depth clinical reviews on mast cell disorders, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives - p. 627 10. KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted Therapies - p. 651 11. Pediatric and Hereditary Mastocytosis - p. 665 12. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis - p. 681 13. Drug and Venom Allergy in Mastocytosis - p. 699 14. Gastrointestinal Disease in Mastocytosis - p. 711 15. Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms - p. 723 16. Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis - p. 743 17. Measuring Symptom Severity and Quality of Life in Mastocytosis - p. 751 18. Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis - p. 763 19. Update on Mast Cell Proteases as Drug Targets - p. 777
In this issue of Immunology & Allergy Clinics, guest editor Dr. Cem Akin brings his considerable expertise to the topic of Mast Cell Disorders. Top experts in the field provide readers with information on the identification, management, and treatment of mast cell disorders and mastocytosis.
Contains 9 relevant, practice-oriented topics including drug and venom allergy in mastocytosis; quality of life in mastocytosis; effect of gender and special considerations for women in mastocytosis and anaphylaxis; management of mediator symptoms, allergy, and anaphylaxis in mastocytosis; and more.
Provides in-depth clinical reviews on mast cell disorders, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives - p. 627 10. KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted Therapies - p. 651 11. Pediatric and Hereditary Mastocytosis - p. 665 12. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis - p. 681 13. Drug and Venom Allergy in Mastocytosis - p. 699 14. Gastrointestinal Disease in Mastocytosis - p. 711 15. Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms - p. 723 16. Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis - p. 743 17. Measuring Symptom Severity and Quality of Life in Mastocytosis - p. 751 18. Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis - p. 763 19. Update on Mast Cell Proteases as Drug Targets - p. 777
